UFP Technologies (UFPT) investor relations material

Strategic positioning and market overview

• Focuses on contract development and manufacturing for medical devices and sterile packaging, with a $600M revenue and $2.5B market cap.

• Operates globally with over 5,000 employees and presence in the US, Puerto Rico, Ireland, Mexico, Costa Rica, and the Dominican Republic.

• Embedded in high-growth, long-life-cycle medical device segments, providing materials and engineering that are critical to device performance.

• Benefits from high switching costs and regulatory barriers, creating durable customer relationships and recurring revenue.

• Addresses a highly fragmented $100B outsourced medical device market, holding less than 1% share.

Business model and differentiation

• Engages customers early in the design process, influencing device development and securing long-term manufacturing roles.

• Offers a scalable global manufacturing platform, supporting customers from prototyping to full production.

• Maintains durable relationships due to significant switching costs and regulatory requirements.

• Supplier network provides preferred access to materials and cost advantages, compounding value.

• Flexible model allows expansion into new segments and technologies as the market evolves.

Growth strategy and financial framework

• Pursues organic growth by innovating in materials and converting early partnerships into long-term programs.

• Executes customer-centric M&A to add segments, customers, technologies, and geographic reach.

• Targets 12%-18% annual revenue growth, 28%-31% gross margins, and 17%-20% adjusted operating margins over 3-5 years.

• Disciplined capital allocation focuses on technology and segment advantages, with careful leverage management.

• Experienced management team combines long-tenured leaders, external professionals, and talent from acquisitions.